A tumor metabolite impacting immunotherapy efficacy: Cholesterol sulfate regulates tumor-immune interactions
(Keystone Symposia "Cancer Immunotherapy: Mechanisms of Response versus Resistance" 2023)
DOCK1 as a novel molecular target for controlling cancer cell survival and invasion
(25th Biennial Congress on the European Association for Cancer Research 2018)
Professional career (1):
薬学博士 (東京大学)
Awards (1):
2017/09 - 公益財団法人 内藤記念科学振興財団 内藤記念科学奨励金・研究助成
Association Membership(s) (3):
日本がん免疫学会
, 日本生理学会
, The Japanese Biochemical Society